These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9289238)

  • 1. [The therapeutic and diagnostic contribution of ceftazidime (Fortum) in Pseudomonas aeruginosa superinfection in a patient with chronic bronchopathy].
    Mihălţan F; Ulmeanu R; Ciprut T; Dragoş M
    Pneumoftiziologia; 1997; 46(1):53-7. PubMed ID: 9289238
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
    Ng EW; D'Amico DT
    Retina; 1997; 17(5):464-5. PubMed ID: 9355203
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudomonas aeruginosa meningitis treated with ceftazidime.
    Gopal V; Burke C
    Mil Med; 1990 Jun; 155(6):264-5. PubMed ID: 2122303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position of ceftazidime in respiratory diseases.
    Ando' F; Girbino G; Ferrara F
    Drugs Exp Clin Res; 1985; 11(6):369-72. PubMed ID: 3915288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime.
    Davies BI; Maesen FP; van Noord JA
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():1-8. PubMed ID: 6352611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1976.
    N Engl J Med; 1976 Aug; 295(6):328-34. PubMed ID: 934212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monotherapy of systematic Pseudomonas aeruginosa infections with ceftazidime. The causes of therapeutic failures].
    Blaser J; Bauernfeind A; Vogt M; Lüthy R
    Dtsch Med Wochenschr; 1983 Sep; 108(35):1312-7. PubMed ID: 6411442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime in patients with Pseudomonas infections.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():161-9. PubMed ID: 6225762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spontaneous bacterial peritonitis caused by Pseudomonas aeruginosa].
    Montalvo II; Gil I; Arriola JA; Arenas JI
    Gastroenterol Hepatol; 1996 Nov; 19(9):489. PubMed ID: 8998675
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of Pseudomonas aeruginosa meningitis with ceftazidime.
    Elliott TS; Ispahani P; Choudhary BP
    J Infect; 1983 Nov; 7(3):275-7. PubMed ID: 6363565
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fortum in perioperative prophylaxis].
    Zalewski P; Olszewski J; Kotyło P
    Otolaryngol Pol; 1995; 49 Suppl 20():196-8. PubMed ID: 9454134
    [No Abstract]   [Full Text] [Related]  

  • 13. Cephalosporin therapeutics in cystic fibrosis.
    Blumer JL; Stern RC; Yamashita TS; Myers CM; Reed MD
    J Pediatr; 1986 May; 108(5 Pt 2):854-60. PubMed ID: 3517273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Pseudomonas aeruginosa meningitis with ceftazidime.
    Modai J; Meulemans A; Vittecoq D
    J Antimicrob Chemother; 1983 Feb; 11(2):198-9. PubMed ID: 6339463
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo efficacy of ceftolozane against Pseudomonas aeruginosa in a rabbit experimental model of pneumonia: comparison with ceftazidime, piperacillin/tazobactam and imipenem.
    Bretonnière C; Boutoille D; Caillon J; Desessard C; Guitton C; Potel G; Jacqueline C
    Int J Antimicrob Agents; 2014 Sep; 44(3):218-21. PubMed ID: 25108877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plastic bronchitis].
    Leroyer C; Couturaud F; Chenu E; Le Ber C; Petitet C; Eveilleau C; Clavier J
    Rev Mal Respir; 1995; 12(6):622-4. PubMed ID: 8677357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Adamis T; Koussoulas V; Baziaka F; Perrea D; Karayannacos PE; Giamarellou H
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of bone infections with ceftazidime.
    Dutoy JP; Wauters G
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():229-33. PubMed ID: 6352624
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp.
    Rusconi F; Assael BM; Florioli A; Zaffaroni G
    Antimicrob Agents Chemother; 1984 Mar; 25(3):395-7. PubMed ID: 6372686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.